They demonstrated that S100A14 is located at the apical pole of tumor cells, where it interacts with lactotransferrin (LTF) in resident tumor macrophages, which is associated with a favorable response to treatment, suggesting that S100A14 may play a crucial role in mediating communication between tumor cells and the immune microenvironment. Here, LTF is linked to neoplasm.